1. Hemorrhage.
2. Diarrhea.
3. Thrombocytopenia.
4. QTc interval prolongation.
5. Major adverse cardiac events (MACE).
6. Thrombosis.
7. Secondary malignancies.
8. Infection risk.
FDA,2025.10